Financhill
Sell
38

JAGX Quote, Financials, Valuation and Earnings

Last price:
$0.96
Seasonality move :
32.26%
Day range:
$0.88 - $0.98
52-week range:
$0.84 - $21.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
0.81x
Volume:
527.1K
Avg. volume:
457.3K
1-year change:
-89.56%
Market cap:
$11.1M
Revenue:
$9.8M
EPS (TTM):
-$16.18
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $5.8M $9.4M $4.3M $12M $9.8M
Revenue Growth (YoY) 30.77% 62.51% -53.81% 175.8% -18.36%
 
Cost of Revenues $3.8M $3.3M $2.3M $2M $2M
Gross Profit $2M $6.1M $2M $9.9M $7.7M
Gross Profit Margin 33.92% 65.05% 46.18% 83.11% 79.13%
 
R&D Expenses $5.8M $6.4M $15.1M $17.6M $18.6M
Selling, General & Admin $20.4M $21M $26M $26.7M $23M
Other Inc / (Exp) -$7.9M -$4.4M -$3.5M -$1.3M -$1.6M
Operating Expenses $26.9M $27.4M $41.1M $44.4M $41.6M
Operating Income -$24.9M -$21.3M -$39.1M -$34.4M -$33.9M
 
Net Interest Expenses $5.7M $8.1M $10.1M $12.7M $6.4M
EBT. Incl. Unusual Items -$38.5M -$33.8M -$52.6M -$48.4M -$41.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $10K -- -- -- --
Net Income to Company -$38.5M -$33.8M -$52.6M -$49.1M -$41.9M
 
Minority Interest in Earnings -- -- $5K $941K $601K
Net Income to Common Excl Extra Items -$38.5M -$33.8M -$52.6M -$47.5M -$41.3M
 
Basic EPS (Cont. Ops) -$41,996.24 -$13,500.00 -$5,160.87 -$2,170.80 -$107.40
Diluted EPS (Cont. Ops) -$41,996.24 -$13,500.00 -$5,160.87 -$2,170.80 -$107.40
Weighted Average Basic Share $1.1K $2.9K $10.2K $21.9K $384.5K
Weighted Average Diluted Share $1.1K $2.9K $10.2K $21.9K $384.5K
 
EBITDA -$30.9M -$28.7M -$42.4M -$33.4M -$33.1M
EBIT -$32.8M -$31M -$44.2M -$35.7M -$35.5M
 
Revenue (Reported) $5.8M $9.4M $4.3M $12M $9.8M
Operating Income (Reported) -$24.9M -$21.3M -$39.1M -$34.4M -$33.9M
Operating Income (Adjusted) -$32.8M -$31M -$44.2M -$35.7M -$35.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.8M $630K $3.2M $2.8M $3.1M
Revenue Growth (YoY) 185% -77.28% 400% -10.7% 10.49%
 
Cost of Revenues $784K $617K $613K $514K $541K
Gross Profit $2M $13K $2.5M $2.3M $2.6M
Gross Profit Margin 71.73% 2.06% 80.54% 81.73% 82.59%
 
R&D Expenses $1.5M $3.3M $5.9M $6.1M $4M
Selling, General & Admin $5.8M $6.2M $6.5M $5M $5.8M
Other Inc / (Exp) -$1.9M -$585K $18K $1.4M -$2.9M
Operating Expenses $7.4M $9.5M $12.4M $11.1M $9.8M
Operating Income -$5.4M -$9.5M -$9.9M -$8.8M -$7.3M
 
Net Interest Expenses $581K $2.1M $2.7M $500K --
EBT. Incl. Unusual Items -$7.9M -$12.2M -$12.6M -$7.9M -$10M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$7.9M -$12.2M -$12.6M -$8M -$10.2M
 
Minority Interest in Earnings -- -- $89K $126K $167K
Net Income to Common Excl Extra Items -$7.9M -$12.2M -$12.5M -$7.8M -$9.9M
 
Basic EPS (Cont. Ops) -$2,790.00 -$1,215.00 -$529.80 -$22.50 -$1.05
Diluted EPS (Cont. Ops) -$2,790.00 -$1,215.00 -$529.80 -$22.50 -$1.05
Weighted Average Basic Share $3K $10.2K $23.6K $345.7K $9.4M
Weighted Average Diluted Share $3K $10.2K $23.6K $345.7K $9.4M
 
EBITDA -$6.7M -$9.6M -$9.3M -$8.2M -$6.7M
EBIT -$7.3M -$10.1M -$9.9M -$8.8M -$7.3M
 
Revenue (Reported) $2.8M $630K $3.2M $2.8M $3.1M
Operating Income (Reported) -$5.4M -$9.5M -$9.9M -$8.8M -$7.3M
Operating Income (Adjusted) -$7.3M -$10.1M -$9.9M -$8.8M -$7.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $8.3M $4.8M $10.8M $10.7M $10.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.2M $2.7M $2M $1.8M $2.1M
Gross Profit $5.1M $2.2M $8.8M $8.9M $8.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.9M $11.5M $18.8M $19.4M $15.5M
Selling, General & Admin $21.1M $24.1M $28.9M $22.5M $22.8M
Other Inc / (Exp) -$2.3M -$4.5M -$3.6M $964K -$7.9M
Operating Expenses $27M $35.6M $47.7M $41.9M $38.3M
Operating Income -$22M -$33.4M -$39M -$33M -$29.9M
 
Net Interest Expenses $6.8M $9.2M $11.9M $8.8M $589K
EBT. Incl. Unusual Items -$31M -$47.1M -$54.5M -$40.8M -$38.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$31M -$47.1M -$54.5M -$41.6M -$38.2M
 
Minority Interest in Earnings -- -- $295K $1.1M $584K
Net Income to Common Excl Extra Items -$31M -$47.1M -$54.2M -$39.7M -$37.7M
 
Basic EPS (Cont. Ops) -$23,818.65 -$5,215.49 -$3,687.87 -$415.70 -$16.18
Diluted EPS (Cont. Ops) -$23,818.65 -$5,215.49 -$3,774.06 -$415.70 -$16.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$27.6M -$37.8M -$40.4M -$30.3M -$29.6M
EBIT -$29.6M -$39.5M -$42.6M -$32.7M -$32M
 
Revenue (Reported) $8.3M $4.8M $10.8M $10.7M $10.5M
Operating Income (Reported) -$22M -$33.4M -$39M -$33M -$29.9M
Operating Income (Adjusted) -$29.6M -$39.5M -$42.6M -$32.7M -$32M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.8M $2.3M $8.7M $7.5M $8.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.5M $1.9M $1.5M $1.4M $1.4M
Gross Profit $4.3M $392K $7.2M $6.1M $6.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $4.5M $9.6M $13.3M $15.1M $12M
Selling, General & Admin $15.9M $19M $22M $17.7M $17.4M
Other Inc / (Exp) -$2.3M -$2.4M -$2.6M $276K -$6M
Operating Expenses $20.5M $28.6M $35.3M $32.8M $29.5M
Operating Income -$16.1M -$28.2M -$28.1M -$26.7M -$22.7M
 
Net Interest Expenses $6.6M $7.6M $9.5M $6.1M $611K
EBT. Incl. Unusual Items -$25M -$38.3M -$40.2M -$32.6M -$29M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$25M -$38.3M -$40.2M -$32.7M -$29.1M
 
Minority Interest in Earnings -- -- $290K $462K $445K
Net Income to Common Excl Extra Items -$25M -$38.3M -$39.9M -$32.1M -$28.6M
 
Basic EPS (Cont. Ops) -$16,290.01 -$3,870.00 -$2,442.00 -$207.25 -$8.69
Diluted EPS (Cont. Ops) -$16,290.01 -$3,870.00 -$2,442.00 -$207.25 -$8.69
Weighted Average Basic Share $5.9K $29.7K $54.4K $724.7K $14.4M
Weighted Average Diluted Share $5.9K $29.7K $54.4K $724.7K $14.4M
 
EBITDA -$21.9M -$31M -$29M -$25.3M -$21.5M
EBIT -$23.8M -$32.3M -$30.7M -$27.1M -$23.2M
 
Revenue (Reported) $6.8M $2.3M $8.7M $7.5M $8.2M
Operating Income (Reported) -$16.1M -$28.2M -$28.1M -$26.7M -$22.7M
Operating Income (Adjusted) -$23.8M -$32.3M -$30.7M -$27.1M -$23.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.5M $8.1M $17.1M $5.5M $6.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.7M $4.5M $1.7M $1.9M $2M
Inventory $2.1M $2.8M $4.9M $7M $9.2M
Prepaid Expenses $1.3M $2.4M -- -- --
Other Current Assets $553K -- $4.3M $7.4M $10.1M
Total Current Assets $9.5M $17.8M $28.4M $22.3M $28M
 
Property Plant And Equipment $710K $677K $1.7M $1.7M $1.7M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $26M $24.3M $22.7M $22.4M $20.1M
Other Long-Term Assets $154K $37K $446K $995K $1M
Total Assets $36.4M $42.8M $53.3M $47.5M $50.8M
 
Accounts Payable $5.4M $4.8M $4.9M $5.8M $5M
Accrued Expenses $2.7M $4.4M $6.6M $7.6M $3.5M
Current Portion Of Long-Term Debt $6.8M $3.8M $3.2M $15.9M $4.9M
Current Portion Of Capital Lease Obligations $337K -- $240K $483K $348K
Other Current Liabilities $3K $179K $1K -- --
Total Current Liabilities $15.4M $13.2M $15.5M $30.3M $14M
 
Long-Term Debt $450K $12.4M $25M $17.7M $31M
Capital Leases -- -- -- -- --
Total Liabilities $25.7M $25.6M $41.4M $48.8M $45.9M
 
Common Stock $1.7M $4K -- -- $7K
Other Common Equity Adj -- -- -- -$680K -$652K
Common Equity $9M $17.2M $11.6M -$657K $5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $242K -$699K -$64K
Total Equity $10.7M $17.2M $11.9M -$1.4M $4.9M
 
Total Liabilities and Equity $36.4M $42.8M $53.3M $47.5M $50.8M
Cash and Short Terms $3.5M $8.1M $17.1M $5.5M $6.5M
Total Debt $7.2M $16.2M $28.2M $33.6M $35.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.3M $12.4M $10.6M $3.2M $13.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.7M $2.1M $1.8M $1.7M $1.2M
Inventory $2.2M $4.5M $6.6M $8.4M $9.7M
Prepaid Expenses $2.5M $4.9M $5.6M -- --
Other Current Assets -- -- -- $8.6M $12.4M
Total Current Assets $10.7M $24M $25.2M $22.1M $36.6M
 
Property Plant And Equipment $686K $1.7M $1.7M $1.3M $1.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $24.8M $23.1M $22.6M $21M $18.9M
Other Long-Term Assets $66K -- $1.8M $1M $1.3M
Total Assets $36.2M $59.3M $51.3M $45.4M $58.5M
 
Accounts Payable $5.5M $3.8M $6.3M $5.1M $4.6M
Accrued Expenses $7M $6.1M $8.5M $3.3M $3.3M
Current Portion Of Long-Term Debt $6.8M $1.8M $11.7M $3.5M $11.5M
Current Portion Of Capital Lease Obligations -- $297K $418K $526K $368K
Other Current Liabilities $6.6M $3K -- -- --
Total Current Liabilities $25.8M $12M $26.9M $12.5M $19.9M
 
Long-Term Debt $2.7M $24.9M $20M $31.2M $21.7M
Capital Leases -- -- -- -- --
Total Liabilities $28.4M $37.7M $47.7M $44M $45.4M
 
Common Stock $5.7M $5K $13K $2K $1K
Other Common Equity Adj -- -- -- -$796K -$687K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -$48K $56K -$514K
Total Equity $7.8M $21.6M $3.6M $1.4M $13.1M
 
Total Liabilities and Equity $36.2M $59.3M $51.3M $45.4M $58.5M
Cash and Short Terms $1.3M $12.4M $10.6M $3.2M $13.3M
Total Debt $9.4M $26.7M $31.7M $34.7M $33.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$38.5M -$33.8M -$52.6M -$49.1M -$41.9M
Depreciation & Amoritzation $1.9M $2.3M $1.8M $2.3M $2.4M
Stock-Based Compensation $3M $2.8M $4M $3.3M $2.1M
Change in Accounts Receivable -$704K -$2.9M $2.4M -$421K $298K
Change in Inventories $1.2M -$653K -$2.1M -$2.1M -$2.2M
Cash From Operations -$20.5M -$15.3M -$35M -$33.1M -$33.2M
 
Capital Expenditures -- $7K $6K $1.7M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$7K -$6K -$1.7M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $5.1M $12.3M $11M $4M --
Long-Term Debt Repaid -$5.2M -$6.6M -$1.9M -$100K -$100K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2.6M $6M -$731K -$1.2M $380K
Cash From Financing $21.8M $19.5M $43.9M $23.2M $34.2M
 
Beginning Cash (CF) $2.6M $3.9M $8.1M $17.1M $5.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.3M $4.2M $9M -$11.6M $985K
Ending Cash (CF) $3.9M $8.1M $17.1M $5.5M $6.5M
 
Levered Free Cash Flow -$20.5M -$15.3M -$35M -$34.8M -$33.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$7.9M -$12.2M -$12.6M -$8M -$10.2M
Depreciation & Amoritzation $621K $473K $587K $625K $596K
Stock-Based Compensation $675K $1.2M $745K $528K $305K
Change in Accounts Receivable -$703K $2M -$412K -$296K $64K
Change in Inventories $135K -$1.1M $144K -$115K -$118K
Cash From Operations -$2.9M -$9.4M -$8.5M -$6.8M -$6.3M
 
Capital Expenditures -- -- $56K -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$10.5M -$56K -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $776K -- $4M -- --
Long-Term Debt Repaid -$1.6M -$688K -$68K $293K $216K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $1.5M $281K $18K -$313K -$437K
Cash From Financing $1.3M $373K $10.1M $1.4M $3.5M
 
Beginning Cash (CF) $3M $31.9M $9M $8.6M $16M
Foreign Exchange Rate Adjustment -- -- -$15K -$20K $31K
Additions / Reductions -$1.7M -$19.5M $1.6M -$5.4M -$2.8M
Ending Cash (CF) $1.3M $12.4M $10.6M $3.2M $13.3M
 
Levered Free Cash Flow -$2.9M -$9.4M -$8.6M -$6.8M -$6.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$31M -$47.1M -$54.5M -$41.6M -$38.2M
Depreciation & Amoritzation $1.9M $1.8M $2.2M $2.4M $2.4M
Stock-Based Compensation $3.2M $3.5M $4.1M $1.9M $1.8M
Change in Accounts Receivable -$3.1M $2.5M -$391K $653K $554K
Change in Inventories $103K -$2.3M -$2.1M -$1.8M -$1.3M
Cash From Operations -$14.4M -$30.1M -$35.6M -$32.2M -$29M
 
Capital Expenditures $7K $6K $1.3M $361K $16K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$7K -- $9.2M -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $1.1M $22.1M -- -- --
Long-Term Debt Repaid -$3.1M -$6M $470K -$32K -$150K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $1.7M -$796K -$122K --
Cash From Financing $13.6M $51.6M $24.7M $25.2M $39M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$721K $11M -$1.8M -$7.4M $10M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$14.4M -$30.1M -$36.9M -$32.6M -$29M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$25M -$38.3M -$40.2M -$32.7M -$29.1M
Depreciation & Amoritzation $1.8M $1.3M $1.7M $1.8M $1.8M
Stock-Based Compensation $2.2M $2.8M $2.9M $1.5M $1.3M
Change in Accounts Receivable -$3M $2.4M -$452K $622K $878K
Change in Inventories -$90K -$1.7M -$1.7M -$1.4M -$485K
Cash From Operations -$11.2M -$26M -$26.7M -$25.8M -$21.6M
 
Capital Expenditures $7K $6K $1.3M -- $16K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$7K -$10.5M -$1.3M -- -$16K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.1M $11M $4M -- --
Long-Term Debt Repaid -$3.1M -$2.5M -$118K -$50K -$100K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $4.4M -$35K -$100K $934K -$437K
Cash From Financing $8.7M $40.8M $21.5M $23.6M $28.4M
 
Beginning Cash (CF) $8.5M $72.3M $43.5M $28.5M $34.2M
Foreign Exchange Rate Adjustment -- -- -$38K -$29K $2K
Additions / Reductions -$2.5M $4.3M -$6.5M -$2.2M $6.8M
Ending Cash (CF) $6M $76.5M $37M $26.2M $41M
 
Levered Free Cash Flow -$11.2M -$26.1M -$28M -$25.8M -$21.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock